Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy

February 28-March 3, 2027
JW Marriott Los Angeles L.A. Live
Los Angeles, California

sign up to request additional information

Cochairs

Nina Bhardwaj, Icahn School of Medicine at Mount Sinai, New York, New York
Elizabeth M. Jaffee, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Antoni Ribas, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California

Building on the success of the 2025 and 2026 AACR IO conferences, AACR invites you to join us again in Los Angeles for AACR IO 2027.  The third conference in this series will once again encompass the very best of basic, translational, and clinical research in immunology, inflammation, and immunotherapies for cancer, including immuno-oncology (IO) drugs, inflammatory modulators, vaccines, and cellular therapies. This conference has attracted over 600 basic scientists, translational researchers, clinical investigators, regulators, industry, investors, and the lay press – and we anticipate a larger audience in 2027. The program will once again include a mix of keynote lectures, major symposia, spotlight sessions, educational sessions, and poster sessions with exhibits will cover the spectrum of the IO field – including late-breaking clinical trials sessions highlighting new agents and novel IO combinations, and the results of practice-changing clinical trials. Make plans to join AACR today for this unique opportunity to network with immuno-oncology thought-leaders from around the world.

Please Note: All presentations at this event represent the opinions of the presenter and do not represent the position or the opinion of the AACR or its members.